Activation of epidermal toll-like receptor 2 enhances tight junction function: Implications for atopic dermatitis and skin barrier repair

Journal of Investigative Dermatology

Volumn 133, Issue 4, 2013, Pages 988-998

  Kuo, I Hsin ^a   Carpenter Mendini, Amanda ^a   Yoshida, Takeshi ^a   McGirt, Laura Y ^b   Ivanov, Andrei I ^a   Barnes, Kathleen C ^c   Gallo, Richard L ^d   Borkowski, Andrew W ^d   Yamasaki, Kenshi ^e   Leung, Donald Y ^f   Georas, Steve N ^a   De Benedetto, Anna ^a   Beck, Lisa A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCCLUDIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; ZONULAE OCCLUDENS 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; EPIDERMIS; FEMALE; INNATE IMMUNITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIGHT JUNCTION; TISSUE REPAIR; WOUND HEALING;

EID: 84875220580     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.437     Document Type: Article

References (74)

1. Aberg KM, Man MQ, Gallo RL et al. (2008) Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128:917-25
2. Ahrens K, Schunck M, Podda GF et al. (2011) Mechanical and metabolic injury to the skin barrier leads to increased expression of murine beta-defensin- 1, -3, and -14. J Invest Dermatol 131:443-52
3. Amagai M, Matsuyoshi N, Wang ZH et al. (2000) Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6:1275-7
4. Antiga E, Volpi W, Torchia D et al. (2011) Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis. Clin Exp Dermatol 36:235-41
5. Baker BS, Ovigne JM, Powles AV et al. (2003) Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 148:670-9
6. Baltes S, Nau H, Lampen A (2004) All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serumfree conditions. Dev Growth Differ 46:503-14
7. Benakanakere MR, Li Q, Eskan MA et al. (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 284:23107-15
8. Bochud PY, Magaret AS, Koelle DM et al. (2007) Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis 196:505-9
9. Boguniewicz M, Leung DY (2010) Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125:4-13
10. Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233-46
11. Borkowski AW, Gallo RL (2011) The coordinated response of the physical and antimicrobial peptide barriers of the skin. J Invest Dermatol 131:285-7
12. Cario E, Gerken G, Podolsky DK (2004) Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127:224-38
13. Cario E, Gerken G, Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-74
14. Cork MJ, Robinson DA, Vasilopoulos Y et al. (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3-21
15. De Benedetto A, Agnihothri R, McGirt LY et al. (2009) Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 129:14-30
16. De Benedetto A, Kubo A, Beck LA (2012) Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 132:949-63
17. De Benedetto A, Rafaels NM, McGirt LY et al. (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127:773-86.e1-7
18. Dickel H, Gambichler T, Kamphowe J et al. (2010) Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNFalpha and IL-8/CXCL8 mRNA: new insights into the involvement of 'alarmins'. Contact Dermatitis 63:215-22
19. Djalilian AR, McGaughey D, Patel S et al. (2006) Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 116:1243-53
20. El Asmar R, Panigrahi P, Bamford P et al. (2002) Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123:1607-15
21. Elias PM, Hatano Y, Williams ML (2008) Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121:1337-43
22. Furuse M, Furuse K, Sasaki H et al. (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263-72
23. Furuse M, Hata M, Furuse K et al. (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1- deficient mice. J Cell Biol 156:1099-111
24. Gareus R, Huth M, Breiden B et al. (2007) Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 9:461-9
25. Grether-Beck S, Felsner I, Brenden H et al. (2012) Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 132:1561-72
26. Grigoryev DN, Howell MD, Watkins TN et al. (2010) Vaccinia virus-specific molecular signature in atopic dermatitis skin. J Allergy Clin Immunol 125:153-9.e28
27. Hasannejad H, Takahashi R, Kimishima M et al. (2007) Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 120:69-75
28. Howell MD, Kim BE, Gao P et al. (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124:R7-12
29. Imokawa G (2001) Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 45:S29-32
30. Jensen JM, Schutze S, Forl M et al. (1999) Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 104:1761-70
31. Jin H, Kumar L, Mathias C et al. (2009) Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol 123:875-82 e1
32. Jurkin J, Schichl YM, Koeffel R et al. (2010) miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. J Immunol 184:4955-65
33. Kollisch G, Kalali BN, Voelcker V et al. (2005) Various members of the Tolllike receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114:531-41
34. Koschwanez HE, Broadbent E (2011) The use of wound healing assessment methods in psychological studies: a review and recommendations. Br J Health Psychol 16:1-32
35. Kretz M, Maass K, Willecke K (2004) Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur J Cell Biol 83:647-54
36. Kubo A, Nagao K, Amagai M (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 122:440-7
37. Liu G, Friggeri A, Yang Y et al. (2009) miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 106:15819-24
38. Liu Y, Wang Y, Yamakuchi M et al. (2001) Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation. Infect Immun 69:2788-96
39. Lucke T, Choudhry R, Thom R et al. (1999) Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 112:354-61
40. Ma TY, Iwamoto GK, Hoa NT et al. (2004) TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286:G367-76
41. Marchiando AM, Shen L, Graham WV et al. (2010) Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189:111-26
42. Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121: 1389-96
43. Menzies BE, Kenoyer A (2006) Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74:6847-54
44. Mrabet-Dahbi S, Dalpke AH, Niebuhr M et al. (2008) The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 121:1013-9
45. Murata Y, Ogata J, Higaki Y et al. (1996) Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 106:1242-9
46. Nahid MA, Satoh M, Chan EK (2011) Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 186:1723-34
47. Niebuhr M, Lutat C, Sigel S et al. (2009) Impaired TLR-2 expression and TLR-2- mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 64:1580-7
48. Niessen CM (2007) Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 127:2525-32
49. Ohnemus U, Kohrmeyer K, Houdek P et al. (2008) Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol 128:906-16
50. Olaru F, Jensen LE (2010) Staphylococcus aureus stimulates neutrophil targeting chemokine expression in keratinocytes through an autocrine IL-1alpha signaling loop. J Invest Dermatol 130:1866-76
51. Ong PY, Leung DY (2010) The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am 30:309-21
52. Ozinsky A, Underhill DM, Fontenot JD et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97:13766-71
53. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. (2006) Common loss-offunction variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-6
54. Pilgram GS, Vissers DC, van der Meulen H et al. (2001) Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 117:710-7
55. Rezaee F, Meednu N, Emo JA et al. (2011) Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells. J Allergy Clin Immunol 128:1216-24 e11
56. Sato A, Linehan MM, Iwasaki A (2006) Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 103:17343-8
57. Schauber J, Dorschner RA, Coda AB et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-11
58. Schroder NW, Morath S, Alexander C et al. (2003) Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278:15587-94
59. Schwandner R, Dziarski R, Wesche H et al. (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274:17406-9
60. Shuto T, Imasato A, Jono H et al. (2002) Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277:17263-70
61. Takeuchi O, Hoshino K, Akira S (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-6
62. Takeuchi O, Hoshino K, Kawai T et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-51
63. Taljebini M, Warren R, Mao-Oiang M et al. (1996) Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. Skin Pharmacol 9:111-9
64. Tsan MF, Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514-9
65. Tunggal JA, Helfrich I, Schmitz A et al. (2005) E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 24:1146-56
66. Utech M, Ivanov AI, Samarin SN et al. (2005) Mechanism of IFN-gammainduced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16:5040-52
67. Vasilopoulos Y, Cork MJ, Teare D et al. (2007) A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy 62:514-9
68. Wang XP, Schunck M, Kallen KJ et al. (2004) The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 123:124-31
69. Warner RR, Boissy YL, Lilly NA et al. (1999) Water disrupts stratum corneum lipid lamellae: damage is similar to surfactants. J Invest Dermatol 113:960-6
70. Warner RR, Stone KJ, Boissy YL (2003) Hydration disrupts human stratum corneum ultrastructure. J Invest Dermatol 120:275-84
71. Yoshimura A, Lien E, Ingalls RR et al. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163:1-5
72. Yuki T, Hachiya A, Kusaka A et al. (2011a) Characterization of tight junctions and their disruption by UVB in human epidermis and cultured keratinocytes. J Invest Dermatol 131:744-52
73. Yuki T, Yoshida H, Akazawa Y et al. (2011b) Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes. J Immunol 187:3230-7
74. Zahringer U, Lindner B, Inamura S et al. (2008) TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205-24